Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Norepinephrine–dopamine reuptake inhibitor

From Wikipedia, the free encyclopedia
(Redirected fromNorepinephrine–dopamine reuptake inhibitors)
Drug that inhibits the reuptake of norepinephrine and dopamine
Further information:Norepinephrine reuptake inhibitor andDopamine reuptake inhibitor
Norepinephrine–dopamine reuptake inhibitor
Drug class
Methylphenidate, one of the most widely used NDRIs.
Class identifiers
UseADHD,depression,narcolepsy
Mechanism of actionreuptake inhibitor
Biological targetnorepinephrine transporter (NET),
dopamine transporter (DAT)
Legal status
In Wikidata

Anorepinephrine–dopamine reuptake inhibitor (NDRI) is a type ofdrug thatinhibits thereuptake of themonoamine neurotransmittersnorepinephrine anddopamine and thereby increasesextracellular levels of these neurotransmitters andnoradrenergic anddopaminergicneurotransmission.[1] They work bycompetitively and/ornoncompetitively inhibiting thenorepinephrine transporter (NET) anddopamine transporter (DAT).[1]

NDRIs are used clinically in the treatment of conditions includingattention deficit hyperactivity disorder (ADHD),narcolepsy, anddepression. Examples of well-known NDRIs includemethylphenidate andbupropion.

A closely related type of drug is anorepinephrine–dopamine releasing agent (NDRA).

List of NDRIs

[edit]

Many NDRIs exist, including the following:

Some NDRIs, such asmethylphenidate, may not act as simple NDRIs but rather asDAT "inverse agonists" (and possibly also analogously at the NET as well).[3] If this theory is correct, then methylphenidate and other agents likecocaine may not be acting primarily asmonoamine reuptake inhibitors but instead as robustmonoamine releasing agent-esque drugs, albeit via a differentmechanism of action that conventionalsubstrate-type monoamine releasing agents.[3]

Norepinephrine–dopamine releasing agents (NDRAs) likeamphetamine andmethamphetamine not only induce monoamine release but also act as monoamine reuptake inhibitors to a lesser extent and hence are additionally NDRIs.[4][5]

See also

[edit]

References

[edit]
  1. ^abStephen M. Stahl (2 March 2009).Antidepressants. Cambridge University Press. p. 73.ISBN 978-0-521-75852-9. Retrieved10 May 2012.
  2. ^Stahl, SM; Pradko, JF; Haight, BR; Modell, JG; Rockett, CB; Learned-Coughlin, S (2004)."A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor".Primary Care Companion to the Journal of Clinical Psychiatry.6 (4):159–166.doi:10.4088/PCC.v06n0403.ISSN 1523-5998.PMC 514842.PMID 15361919.
  3. ^abHeal DJ, Gosden J, Smith SL (December 2014). "Dopamine reuptake transporter (DAT) "inverse agonism"--a novel hypothesis to explain the enigmatic pharmacology of cocaine".Neuropharmacology.87:19–40.doi:10.1016/j.neuropharm.2014.06.012.PMID 24953830.
  4. ^Rothman RB, Baumann MH (October 2003). "Monoamine transporters and psychostimulant drugs".Eur J Pharmacol.479 (1–3):23–40.doi:10.1016/j.ejphar.2003.08.054.PMID 14612135.
  5. ^Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS (January 2001). "Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin".Synapse.39 (1):32–41.doi:10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3.PMID 11071707.
Adamantanes
Adenosine antagonists
Alkylamines
Ampakines
Arylcyclohexylamines
Benzazepines
Cathinones
Cholinergics
Convulsants
Eugeroics
Oxazolines
Phenethylamines
Phenylmorpholines
Piperazines
Piperidines
Phenethylpyrrolidines
Racetams
Psychedelics
Tropanes
Tryptamines
Others
CNSTooltip central nervous systemstimulants
Non-classical
CNSstimulants
α2-adrenoceptor
agonists
Antidepressants
Miscellaneous/others
Related articles
SSRIsTooltip Selective serotonin reuptake inhibitors
SNRIsTooltip Serotonin–norepinephrine reuptake inhibitors
NRIsTooltip Norepinephrine reuptake inhibitors
NDRIsTooltip Norepinephrine–dopamine reuptake inhibitors
NaSSAsTooltip Noradrenergic and specific serotonergic antidepressants
SARIsTooltip Serotonin antagonist and reuptake inhibitors
SMSTooltip Serotonin modulator and stimulators
Others
TCAsTooltip Tricyclic antidepressants
TeCAsTooltip Tetracyclic antidepressants
Others
Non-selective
MAOATooltip Monoamine oxidase A-selective
MAOBTooltip Monoamine oxidase B-selective
Miscellaneous
Catecholaminergic agents
  • Serotonin–norepinephrine–dopamine reuptake inhibitors (SNDRIs):Mazindol
Orexin receptor agonists
Histamine H3 receptor antagonists
Adenosine receptor antagonists
Others
DATTooltip Dopamine transporter
(DRIsTooltip Dopamine reuptake inhibitors)
NETTooltip Norepinephrine transporter
(NRIsTooltip Norepinephrine reuptake inhibitors)
SERTTooltip Serotonin transporter
(SRIsTooltip Serotonin reuptake inhibitors)
VMATsTooltip Vesicular monoamine transporters
Others
Retrieved from "https://en.wikipedia.org/w/index.php?title=Norepinephrine–dopamine_reuptake_inhibitor&oldid=1315536096"
Category:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp